Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study

AIM: To compare the effect of metformin, a fixed combination of metformin and pioglitazone, or dapagliflozin on insulin resistance in patients with newly diagnosed type 2 diabetes. METHODS: In this 6-week randomized open-label trial, 58 patients were randomly assigned to insulin with metformin, a fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Rui, Yuan, Lu, Shen, Yun, Shen, Ziyang, Ding, Bo, Ma, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518260/
https://www.ncbi.nlm.nih.gov/pubmed/37753480
http://dx.doi.org/10.2147/DMSO.S423322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518260/
https://www.ncbi.nlm.nih.gov/pubmed/37753480
http://dx.doi.org/10.2147/DMSO.S423322

Ejemplares similares